TABLE 1.

Cross-Sectional Analysis^*

Outcome measure	CN− vs. CN+	CN− vs. MCI+	CN− vs. dementia+
TauIQ TauL	1.00 (0.69–1.35), P < 0.10	1.53 (1.21–1.88)	2.70 (2.28–3.26), P < 0.44
SUVR Jack meta-ROI	0.69 (0.39–1.03)	1.58 (1.21–2.01)	2.64 (2.16–3.27)
SUVR Braak I/II	0.55 (0.26–0.85)	1.62 (1.24–2.04), P < 0.64	2.46 (1.98–3.03)
SUVR Braak III/IV	0.57 (0.28–0.88)	1.34 (0.99–1.72)	2.37 (1.93–2.92)
SUVR Braak V/VI	0.49 (0.19–0.80)	0.97 (0.63–1.32)	1.90 (1.48–2.40)

^*Effect sizes with CIs for ¹⁸F-flortaucipir Tau_L and SUVR outcome measures derived from group comparisons. Best-performing method in terms of effect size is highlighted in bold along with probability it is best method.